LIFE SCIENCES, LIFE SCIENCES, VIDEO

Build vs Buy vs Blend: Comparing Challenges and Opportunities for Early-Phase Biopharmaceutical Manufacturing Options

Exploring and comparing various options available to the biopharma industry for the manufacturing of clinical batches Looking at: Internal manufacturing, outsourced manufacturing, and hybrid models What are the current challenges and opportunities for these options?  Discussing various considerations including economic and time — Ravi Samavedam Chief Innovation Officer Azzur Group Ravi Samavedam is a Biochemical Engineer with more than 20 years of experience in the pharmaceutical and biotechnology industries. Before he was appointed Chief Innovation Officer at Azzur Group, he was President and Chief Operating Officer of Azzur Cleanrooms on Demand™. In 2019, Ravi was the General Manager of Azzur…

Continue reading